temozolomide has been researched along with rg2833 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, BD; Chen, L; Li, QZ; Li, WP; Li, ZY; Wang, B; Zhang, XJ | 1 |
1 other study(ies) available for temozolomide and rg2833
Article | Year |
---|---|
Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
Topics: Acetylation; Active Transport, Cell Nucleus; Antineoplastic Agents, Alkylating; Apoptosis; Benzamides; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Central Nervous System Neoplasms; Dacarbazine; Drug Resistance, Neoplasm; Drug Synergism; Glioblastoma; Histone Deacetylase Inhibitors; Homeodomain Proteins; Humans; NF-kappa B; Signal Transduction; Temozolomide; Transcription Factor RelA; Transcription, Genetic; Transcriptional Activation; Tumor Suppressor Proteins | 2016 |